Genotropin Enhances Weight, Muscle Mass in Cancer-Related Cachexia: Two-Year Trial Results
Reading Time: 2 minutes Introduction Cachexia, a debilitating syndrome characterized by severe weight loss, muscle atrophy, and fatigue, significantly impacts the quality of life and prognosis of cancer patients. Among American males diagnosed with cancer, cachexia presents a formidable challenge, necessitating innovative therapeutic approaches. Genotropin, a recombinant human growth hormone, has emerged as a potential treatment option. This article delves into a two-year randomized controlled trial exploring the efficacy of Genotropin in managing cachexia in American males with cancer. Study Design and Methodology The trial, conducted over two years, involved 200 American males diagnosed with various types of cancer and exhibiting signs of cachexia....


